A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome.

Front Cell Neurosci

Centre for Ophthalmology and Visual Sciences (incorporating Lions Eye Institute), The University of Western Australia, Nedlands, WA, Australia.

Published: July 2020

Usher syndrome is a genetic disorder causing neurosensory hearing loss and blindness from retinitis pigmentosa (RP). Adaptive techniques such as braille, digital and optical magnifiers, mobility training, cochlear implants, or other assistive listening devices are indispensable for reducing disability. However, there is currently no treatment to reduce or arrest sensory cell degeneration. There are several classes of treatments for Usher syndrome being investigated. The present article reviews the progress this research has made towards delivering commercial options for patients with Usher syndrome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363968PMC
http://dx.doi.org/10.3389/fncel.2020.00183DOI Listing

Publication Analysis

Top Keywords

usher syndrome
16
review gene
4
gene drug
4
drug cell-based
4
cell-based therapies
4
usher
4
therapies usher
4
syndrome
4
syndrome usher
4
syndrome genetic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!